Stock Earnings Buying Buzz: Prelude Therapeutics Inc [PRLD] Chief Chemistry Officer Combs Andrew purchases 100,000 shares of the company The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Insiders Updates Investing in Prelude Therapeutics Inc (PRLD): What You Must Know Prelude Therapeutics Inc’s filing revealed that its Chief Chemistry Officer Combs Andrew acquired Company’s shares for reported $69250.0 on Mar